Prothena Biosciences today engaged FLG Partners as interim CFO and to effect the spinout of the company from Elan Pharmaceuticals (NYSE:ELN). FLG Partner: Bern Whitney.
Enter your email address below to receive updates from FLG Partners.
Prothena Biosciences today engaged FLG Partners as interim CFO and to effect the spinout of the company from Elan Pharmaceuticals (NYSE:ELN). FLG Partner: Bern Whitney.